Intuitive Surgical, Inc. $ISRG Shares Sold by Thoroughbred Financial Services LLC

Thoroughbred Financial Services LLC lessened its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 26.9% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,012 shares of the medical equipment provider’s stock after selling 1,840 shares during the quarter. Thoroughbred Financial Services LLC’s holdings in Intuitive Surgical were worth $2,241,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Brighton Jones LLC grew its position in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider’s stock valued at $1,916,000 after acquiring an additional 731 shares in the last quarter. Sivia Capital Partners LLC raised its stake in Intuitive Surgical by 3.8% in the second quarter. Sivia Capital Partners LLC now owns 928 shares of the medical equipment provider’s stock valued at $504,000 after buying an additional 34 shares in the last quarter. Schnieders Capital Management LLC. increased its stake in Intuitive Surgical by 38.0% in the second quarter. Schnieders Capital Management LLC. now owns 973 shares of the medical equipment provider’s stock valued at $529,000 after purchasing an additional 268 shares during the last quarter. Rossby Financial LCC lifted its position in shares of Intuitive Surgical by 55.1% during the 2nd quarter. Rossby Financial LCC now owns 304 shares of the medical equipment provider’s stock worth $165,000 after buying an additional 108 shares during the last quarter. Finally, Advisory Alpha LLC boosted its holdings in shares of Intuitive Surgical by 7.0% in the 2nd quarter. Advisory Alpha LLC now owns 2,253 shares of the medical equipment provider’s stock valued at $1,224,000 after buying an additional 147 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analyst Ratings Changes

Several research firms recently commented on ISRG. Royal Bank Of Canada upped their price target on shares of Intuitive Surgical from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Wednesday, December 17th. Raymond James Financial increased their price objective on Intuitive Surgical from $603.00 to $615.00 and gave the stock an “outperform” rating in a research report on Friday, January 23rd. Zacks Research upgraded shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 19th. HSBC increased their price target on shares of Intuitive Surgical from $644.00 to $653.00 and gave the company a “buy” rating in a report on Monday, January 26th. Finally, TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $615.86.

Insider Activity at Intuitive Surgical

In related news, EVP Myriam Curet sold 421 shares of Intuitive Surgical stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $494.96, for a total transaction of $208,378.16. Following the sale, the executive vice president directly owned 409 shares of the company’s stock, valued at $202,438.64. This trade represents a 50.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Gary S. Guthart sold 24,500 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The stock was sold at an average price of $530.10, for a total value of $12,987,450.00. Following the completion of the sale, the director owned 3,694 shares of the company’s stock, valued at $1,958,189.40. This represents a 86.90% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 56,189 shares of company stock worth $30,785,441. 0.70% of the stock is owned by insiders.

Intuitive Surgical Stock Up 2.5%

ISRG opened at $506.17 on Thursday. The business has a fifty day simple moving average of $532.31 and a 200-day simple moving average of $511.29. The firm has a market cap of $179.76 billion, a PE ratio of 64.15, a P/E/G ratio of 3.83 and a beta of 1.65. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share for the quarter, topping the consensus estimate of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The business’s revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $2.21 EPS. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.